The WACC of HLS Therapeutics Inc (HLS.TO) is 5.6%.
| Range | Selected | |
| Cost of equity | 5.30% - 7.20% | 6.25% |
| Tax rate | 4.10% - 8.10% | 6.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.1% - 6.1% | 5.6% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.32 | 0.42 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 5.30% | 7.20% |
| Tax rate | 4.10% | 8.10% |
| Debt/Equity ratio | 0.68 | 0.68 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.1% | 6.1% |
| Selected WACC | 5.6% | |